News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
774,086 Results
Type
Article (69712)
Company Profile (272)
Press Release (704085)
Multimedia
Podcasts (154)
Webinars (27)
Section
Business (203635)
Career Advice (3339)
Deals (37068)
Drug Delivery (143)
Drug Development (86007)
Employer Resources (173)
FDA (17798)
Job Trends (16097)
News (355926)
Policy (36052)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2964)
Academic (2)
Accelerated approval (41)
Adcomms (34)
Allergies (162)
Alliances (51951)
ALS (188)
Alzheimer's disease (1797)
Antibody-drug conjugate (ADC) (364)
Approvals (18016)
Artificial intelligence (629)
Autoimmune disease (194)
Automation (48)
Bankruptcy (370)
Best Places to Work (12334)
BIOSECURE Act (23)
Biosimilars (208)
Biotechnology (185)
Bladder cancer (170)
Brain cancer (68)
Breast cancer (685)
Cancer (5267)
Cardiovascular disease (466)
Career advice (2857)
Career pathing (44)
CAR-T (316)
CDC (63)
Celiac Disease (2)
Cell therapy (850)
Cervical cancer (40)
Clinical research (73297)
Collaboration (1930)
Company closure (6)
Compensation (1075)
Complete response letters (80)
COVID-19 (2931)
CRISPR (108)
C-suite (972)
Cystic fibrosis (157)
Data (6682)
Decentralized trials (2)
Denatured (62)
Depression (161)
Diabetes (543)
Diagnostics (7141)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (43)
Drug discovery (306)
Drug pricing (218)
Drug shortages (33)
Duchenne muscular dystrophy (250)
Earnings (80467)
Editorial (68)
Employer branding (20)
Employer resources (152)
Events (120058)
Executive appointments (1070)
FDA (21163)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (26)
Funding (1637)
Gene editing (229)
Generative AI (62)
Gene therapy (701)
GLP-1 (1121)
Government (5304)
Grass and pollen (8)
Guidances (387)
Healthcare (20303)
HIV (72)
Huntington's disease (50)
IgA nephropathy (87)
Immunology and inflammation (288)
Immuno-oncology (74)
Indications (134)
Infectious disease (3242)
Inflammatory bowel disease (216)
Inflation Reduction Act (16)
Influenza (131)
Intellectual property (267)
Interviews (635)
IPO (17047)
IRA (56)
Job creations (4146)
Job search strategy (2329)
JPM (70)
Kidney cancer (20)
Labor market (88)
Layoffs (639)
Leadership (43)
Legal (8509)
Liver cancer (99)
Longevity (20)
Lung cancer (699)
Lymphoma (396)
Machine learning (49)
Management (59)
Manufacturing (889)
MASH (181)
Medical device (14456)
Medtech (14523)
Mergers & acquisitions (21163)
Metabolic disorders (1423)
mRNA (193)
Multiple sclerosis (178)
NASH (21)
Neurodegenerative disease (373)
Neuropsychiatric disorders (105)
Neuroscience (3191)
Neurotech (1)
NextGen: Class of 2026 (7218)
Non-profit (4960)
Now hiring (45)
Obesity (687)
Opinion (341)
Ovarian cancer (174)
Pain (228)
Pancreatic cancer (252)
Parkinson's disease (318)
Partnered (36)
Patents (541)
Patient recruitment (559)
Peanut (65)
People (64195)
Pharmaceutical (60)
Pharmacy benefit managers (32)
Phase 1 (22787)
Phase 2 (32017)
Phase 3 (23986)
Pipeline (6162)
Policy (343)
Postmarket research (2962)
Preclinical (9910)
Press Release (70)
Prostate cancer (271)
Psychedelics (57)
Radiopharmaceuticals (316)
Rare diseases (1000)
Real estate (6637)
Recruiting (74)
Regulatory (27189)
Reports (46)
Research institute (2699)
Resumes & cover letters (533)
Rett syndrome (31)
RNA editing (19)
RSV (86)
Schizophrenia (163)
Series A (276)
Series B (205)
Service/supplier (8)
Sickle cell disease (107)
Special edition (27)
Spinal muscular atrophy (172)
Sponsored (47)
Startups (3825)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (92)
The Weekly (90)
Vaccines (1153)
Venture capital (101)
Weight loss (456)
Women's health (104)
Worklife (23)
Date
Today (159)
Last 7 days (764)
Last 30 days (3189)
Last 365 days (31507)
2026 (5792)
2025 (31727)
2024 (36362)
2023 (41108)
2022 (52331)
2021 (57178)
2020 (56123)
2019 (49826)
2018 (37959)
2017 (34697)
2016 (34671)
2015 (40280)
2014 (33710)
2013 (29986)
2012 (31659)
2011 (31997)
2010 (30773)
Location
Africa (1059)
Alabama (93)
Alaska (7)
Arizona (293)
Arkansas (15)
Asia (46075)
Australia (8005)
California (11757)
Canada (3402)
China (1207)
Colorado (502)
Connecticut (516)
Delaware (355)
Europe (105468)
Florida (1794)
Georgia (389)
Hawaii (3)
Idaho (65)
Illinois (981)
India (77)
Indiana (562)
Iowa (22)
Japan (468)
Kansas (131)
Kentucky (47)
Louisiana (36)
Maine (85)
Maryland (1469)
Massachusetts (8555)
Michigan (364)
Minnesota (624)
Mississippi (7)
Missouri (145)
Montana (36)
Nebraska (29)
Nevada (135)
New Hampshire (87)
New Jersey (3271)
New Mexico (32)
New York (3153)
North Carolina (1592)
North Dakota (10)
Northern California (5706)
Ohio (366)
Oklahoma (23)
Oregon (44)
Pennsylvania (2365)
Puerto Rico (25)
Rhode Island (47)
South America (1398)
South Carolina (70)
South Dakota (1)
Southern California (4624)
Tennessee (186)
Texas (1872)
United States (42449)
Utah (367)
Vermont (1)
Virginia (290)
Washington D.C. (84)
Washington State (984)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
774,086 Results for "lawrence j ellison institute for transformative medicine of usc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Lawrence J. Ellison Institute for Transformative Medicine of USC Launches Policy Department
The Lawrence J. Ellison Institute for Transformative Medicine of USC is pleased to announce the formation of a Policy Department and the hire of Gabriel Seidman, DrPH, as Director of Policy.
May 4, 2021
·
4 min read
Business
The Lawrence J. Ellison Institute for Transformative Medicine of USC Welcomes Anna Barker
The Lawrence J. Ellison Institute for Transformative Medicine of USC is pleased to announce the appointment of Anna Barker, Ph.D., as its chief strategy officer, effective immediately.
December 5, 2019
·
5 min read
Biotech Beach
Lawrence J. Ellison Institute for Transformative Medicine of USC Explores Breakthrough Tissue “Fingerprints” Concept For Cancer Diagnostics Using Oracle Cloud Technology
The Lawrence J. Ellison Institute for Transformative Medicine of USC (“Ellison Institute”) and Oracle reveal a promising two-step technique to train a high-confidence predictive algorithm for enhanced cancer diagnostics
July 9, 2020
·
8 min read
Press Releases
Northwell’s Feinstein Institutes’ Kevin J. Tracey named to TIME100 2026 Health list
February 12, 2026
·
4 min read
Press Releases
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
January 29, 2026
·
7 min read
Earnings
J&J Aims for $100B in Sales, Puts Stelara Patent Cliff ‘in the Rearview Mirror’
Reporting Q4 and full year earnings on Wednesday, J&J executives hailed growth across the healthcare giant’s portfolio while standing fast on its talc lawsuit and tariffs.
January 21, 2026
·
2 min read
·
Dan Samorodnitsky
IN PARTNERSHIP WITH MEDSIR
Webinar: The Future is Collaborative: Transforming Clinical Trials
This webinar explores how collaborative-initiated trials and Investigator-Initiated Trials (IITs) are complementing traditional drug development to accelerate innovation, advance precision medicine, and address clinically meaningful questions.
March 3, 2026
·
1 min read
·
BioSpace Insights
Business
Ellison Institute Welcomes Dr. Reva Basho as new Director of the Women’s Cancer Program
The Lawrence J. Ellison Institute for Transformative Medicine announced the appointment of Dr. Reva Basho as the Institute’s new Director of the Women’s Cancer Program.
September 21, 2022
·
4 min read
Press Releases
Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference
January 8, 2026
·
12 min read
Press Releases
JOURNAL OF TRANSLATIONAL MEDICINE PUBLISHES PAPER HIGHLIGHTING POTENTIAL OF THE ELEPHAS LIVE™ PLATFORM TO TRANSFORM IMMUNOTHERAPY OUTCOMES
January 7, 2026
·
2 min read
1 of 77,409
Next
